Su-yeon Lee

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Journal: European journal of pharmacology

Published: August 31, 2026

GRP78/BiP as a novel midbody component induces mitotic exit failure via PLK1 stabilization in hepatocellular carcinoma.

GRP78/BiP as a novel midbody component induces mitotic exit failure via PLK1 stabilization in hepatocellular carcinoma.

Journal: BMB reports

Published: July 24, 2026

ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1.

ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1.

Journal: European journal of pharmacology

Published: February 09, 2026

Inhibition of 11β-hydroxysteroid dehydrogenase 1 alleviates pulmonary fibrosis through inhibition of endothelial-to-mesenchymal transition and M2 macrophage polarization by upregulating heme oxygenase-1.

Inhibition of 11β-hydroxysteroid dehydrogenase 1 alleviates pulmonary fibrosis through inhibition of endothelial-to-mesenchymal transition and M2 macrophage polarization by upregulating heme oxygenase-1.

Journal: Cell death & disease

Published: September 27, 2024

Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models.

Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models.

Journal: BMB reports

Published: January 20, 2023

HO-1089 and HO-1197, Novel Herbal Formulas, Have Antitumor Effects via Suppression of PLK1 (Polo-like Kinase 1) Expression in Hepatocellular Carcinoma.

HO-1089 and HO-1197, Novel Herbal Formulas, Have Antitumor Effects via Suppression of PLK1 (Polo-like Kinase 1) Expression in Hepatocellular Carcinoma.

Journal: Cancers

Published: December 15, 2022

Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH.

Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH.

Journal: Cell death & disease

Published: September 06, 2022

The health effects of low blood lead level in oxidative stress as a marker, serum gamma-glutamyl transpeptidase level, in male steelworkers.

The health effects of low blood lead level in oxidative stress as a marker, serum gamma-glutamyl transpeptidase level, in male steelworkers.

Journal: Annals of occupational and environmental medicine

Published: May 30, 2022

Chromenopyrimidinone exhibit antitumor effects through inhibition of CAP1 (Adenylyl cyclase-associated protein 1) expression in hepatocellular carcinoma.

Chromenopyrimidinone exhibit antitumor effects through inhibition of CAP1 (Adenylyl cyclase-associated protein 1) expression in hepatocellular carcinoma.

Journal: Chemico-biological interactions

Published: March 29, 2022

Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression.

Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression.

Journal: Cancer letters

Published: March 05, 2022

Anti-Cancer Activity of Buthus occitanus Venom on Hepatocellular Carcinoma in 3D Cell Culture.

Anti-Cancer Activity of Buthus occitanus Venom on Hepatocellular Carcinoma in 3D Cell Culture.

Journal: Molecules (Basel, Switzerland)

Published: February 02, 2022

Serum Sorbitol Dehydrogenase as a Novel Prognostic Factor for Hepatocellular Carcinoma after Surgical Resection.

Serum Sorbitol Dehydrogenase as a Novel Prognostic Factor for Hepatocellular Carcinoma after Surgical Resection.

Journal: Cancers

Published: October 23, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026